+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pyridoxine for the palmar-plantar erythrodysesthesia syndrome



Pyridoxine for the palmar-plantar erythrodysesthesia syndrome



Annals of Internal Medicine 111(8): 688-689




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041141928

Download citation: RISBibTeXText

PMID: 2529807


Related references

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere. Journal of the National Cancer Institute 85(17): 1432-1433, 1993

Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine?. Asia-Pacific Journal of Clinical Oncology 6(3): 141-143, 2011

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Investigational New Drugs 8(1): 57-63, 1990

Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia. Asia-Pacific Journal of Clinical Oncology 6(3): 155-160, 2011

Pyridoxine as prophylactic therapy for palmar-plantar erythrodysesthesia associated with administration of pegylated liposomal doxorubicin (caelyx): a single-center experience. Oncology 73(3-4): 277-278, 2008

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Annals of Internal Medicine 101(6): 798-799, 1984

Fluorouracil and the palmar-plantar erythrodysesthesia syndrome. Annals of Internal Medicine 102(3): 419, 1985

Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin. Pharmacotherapy 20(10): 1221-1223, 2000

Hand-foot syndrome (palmar-plantar erythrodysesthesia. Schweizerische Medizinische Wochenschrift 130(40): 1413-1416, 2000

Antineoplastic TherapyInduced Palmar Plantar Erythrodysesthesia (Hand-Foot) Syndrome. American Journal of Clinical Dermatology 1(4): 225-234, 2000

Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies. Supportive Cancer Therapy 1(4): 213-218, 2008

Cutaneous toxicity by ftorafur, hand-foot or palmar-plantar erythrodysesthesia syndrome. Revista Clinica Espanola 188(3): 165-166, 1991

Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?. Annals of Oncology 16(7): 1210-1211, 2005

Palmar-plantar erythrodysesthesia syndrome associated with short-term continuous infusion (5 days) of 5-fluorouracil. Tumori 74(3): 329-331, 1988

Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). Annals of Oncology 18(7): 1159-1164, 2007